BioMarin Pharmaceutical Inc.’s $200 Million Credit Facility

Cahill represented the lead arrangers in connection with a $200,000,000 revolving credit facility for BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc., a global biotechnology company focused on developing and commercializing therapies for people with serious and life-threatening rare diseases and medical conditions. Proceeds from the facility will be used for general corporate purposes.

Bank of America, N.A., a national banking association acted as Administrative Agent and Swing Line Lender, and Citibank, N.A. acted as L/C Issuer.

Cahill advised with a team including Michael A. Sherman (Picture), Alex J. Kramer and Juliana Obregon.

Involved fees earner: Michael Sherman – Cahill Gordon & Reindel; Alex Kramer – Cahill Gordon & Reindel; Juliana Obregon – Cahill Gordon & Reindel;

Law Firms: Cahill Gordon & Reindel;

Clients: Citibank; Bank of America;

Author: Ambrogio Visconti